CureVac Taps Bayer to Ramp Up COVID-19 Vaccine Rollout

GALWAY, IRELAND--January 26, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Germany's CureVac wants to accelerate the development of its potential COVID-19 vaccine by recruiting pharmaceutical major Bayer to help get it ready for mass rollout. Within this article: Details CureVac/Bayer alliance, progress of potential COVID-19 vaccine in testing, deal with the EC, related vaccines that have received approval